Dantari is a Los Angeles area company based on cutting edge science from one of the region’s foremost academic institutions, established to meet a profound unmet need in human therapeutics.

Dantari’s platform technology has the potential to allow the transport of small and large molecule therapeutics across the blood brain barrier (BBB). The inability to cross the BBB is not only an impediment to treatment of Central Nervous System (CNS) disorders with many existing drugs, but also represents a formidable challenge for the development of the many novel therapies in the pipeline of CNS-focused companies across the industry.

Dantari scientists are rapidly advancing therapies to treat these patients and provide meaningful medical improvement in their lives.